WAT

NYSE

WATERS CORP /DE/

Health Care, Life Sciences Tools & Services

$406.86

close 7 Aug 2026

+45.68%

52-week change

$39.94B

market cap

$278.49

$414.15

52-week range

Valuation

Market cap$39.94B

P/E (TTM / 5y avg)51.70x34.71x

Forward P/E (FY2026 / FY2027)27.93x24.56x

PEG (TTM / fwd)—2.04

P/S (TTM)10.59x

P/B2.61x

EV/EBITDA (TTM)63.31x

FCF yield (TTM)0.66%

Cash flow & dividend

FCF (TTM)$263.81M

FCF per share (TTM)$2.69

FCF margin (TTM)7.00%

Dividend yield (indicated / 5y avg)——

Annualized dividend—

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+91.39%

Diluted EPS YoY, latest Q-142.86%

Operating margin (TTM)16.01%

Net margin (TTM)11.91%

ROE (latest FY)25.09%

Net debt / EBITDA (TTM)6.73

Interest coverage (TTM)5.85

Price

+0.39%+0.08%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +6%10Y CAGR +4.48%

Diluted EPS

5Y CAGR +5.18%10Y CAGR +6.65%

FCF per share

5Y CAGR -1.82%10Y CAGR +4.72%

Operating cash flow

5Y CAGR -3.76%10Y CAGR +1.30%

Free cash flow

5Y CAGR -2.67%10Y CAGR +1.32%

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -0.90%10Y CAGR -3.09%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date2 Nov 2026bmo

EPS estimate$4.06

Revenue estimate$1.77B

Last reported

Date—

EPS——

Revenue——